Financial Tearsheet






Financial Tearsheet

Cronos Group is an innovative global cannabinoid company with international production and distribution networks across five continents. The Company is committed to building disruptive intellectual property and establishing an iconic brand portfolio.

Stock Chart

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

News Releases

28 Jan 20
Cronos Group Inc. to Hold 2019 Fourth Quarter and Full-Year Conference Call on February 27, 2020
TORONTO , Jan. 28, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2019 Fourth Quarter and Full-Year Earnings Conference Call on Thursday, February 27, 2020 at 8:30 a.m. EST . Cronos Group’s senior management team will discuss
23 Jan 20
Cronos Group Inc. CEO, Mike Gorenstein, to Speak at the 23rd Annual CIBC Western Institutional Investor Conference
TORONTO , Jan. 23, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein , Chairman, President and Chief Executive Officer, will speak at the 23rd Annual CIBC Western Institutional Investor
07 Jan 20
Cronos Group Inc. CEO, Mike Gorenstein, to Present at The ICR Conference 2020
TORONTO , Jan. 07, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein , Chairman, President and Chief Executive Officer, will speak at the ICR Conference 2020 on January 14, 2020 at 9:00 a.m.

SEC Filings

Filing date Description

40FR12B

A statement of beneficial ownership of common stock by certain persons

Amendment to a previously filed 6-K

Events

04 March 2020 at 12:10 PM EST
Cronos Group at Raymond James 41st Annual Institutional Investors Conference
27 February 2020 at 8:30 AM EST
Cronos Group Full Year and Fourth Quarter 2019 Earnings Conference Call
30 January 2020 at 3:15 PM MST
Cronos Group at the 23rd Annual CIBC Western Institutional Investor Conference